🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Wound Healing, Dressing Type, and Dressing Change Frequency in THA

RecruitingNAAges 65 Years - 95 YearsAllClinical Center of Vojvodina
NCT07655388 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Surgical wound complications following primary total hip arthroplasty remain a significant clinical challenge despite advances in wound care technologies. The optimal choice of dressing and frequency of dressing changes remain insufficiently investigated, particularly regarding their influence on wound healing and the wound microenvironment. This prospective, randomized, controlled clinical trial aims to evaluate the impact of dressing type and dressing change frequency on surgical wound healing in patients undergoing primary total hip arthroplasty. Ninety patients will be allocated into three treatment groups receiving either a capillary-action dressing system (VACUTEX™) or standard dressings with different dressing change intervals. The study will assess time to complete wound epithelialization, postoperative wound complications, pain intensity, wound temperature, exudate pH, length

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients scheduled for primary total hip arthroplasty (THA) * Age ≥ 65 years * Ability to provide informed consent * Patients with closed surgical incision suitable for standard postoperative wound care Exclusion Criteria: * Revision hip arthroplasty * Active infection at the time of surgery * Immunosuppressive therapy or severe immunodeficiency * Known allergy to dressing materials used in the study * Severe peripheral vascular disease affecting wound healing * Inability to comply with follow-up protocol
💊

What it tests

  • VACUTEX™ wound dressing
  • Octenisept® wound care dressing
📍

Where

1 site
Clinic for Orthopedic Surgery and Traumatology, University Clinical Center of Vojvodina
Novi Sad, Serbia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy